Vector Blog

More surprises about blood development — and a possible lead for making lymphocytes

Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we’re born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists have long focused on capturing HSCs’ emergence in the embryo, hoping to recreate the process in the lab to provide a...

The post More surprises about blood development — and a possible lead for making lymphocytes appeared first on Vector.

News note: GIANT study homes in on obesity genes

Yes, some obesity is due to genetics. The largest and most powerful study to date has pinned down 14 variants in 13 genes that carry variations associated with body mass index. They provide new clues as to why some people tend to gain weight and have more trouble losing it. Eight of the variants were in...

The post News note: GIANT study homes in on obesity genes appeared first on Vector.

Who We are

The mission of the Technology and Innovation Development Office (TIDO) to maximize the impact of Boston Children’s innovations on patient health while enhancing the research endeavor.

News and Events

Technology Development Fund 2018 Applications now open

The Boston Children’s Technology Development Fund is pleased to launch its 10th funding cycle on January 16, 2018! Letters of Intent (LOI) are due to Technology.Development@childrens.harvard.edu on Feb. 12, 2018.

TIDO is proud to announce the release of our new Inventor’s Guide. The booklet details the commercialization process at Boston Children’s, how to work with TIDO to give your invention the best possibility for success, and answers to frequently asked questions we encounter.

@ChildrensTIDO on Twitter

Connect with us

youtube

Terms and Conditions children's hospital
Site Designed and Developed by Genuine